Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 23 symbols : Abbv save search
Biologics Outsourcing Global Market Report 2022: Emergence of Next Generation Biologics Presents Lucrative Opportunities
Published: 2022-11-23 (Crawled : 18:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.1%
H: 0.62%
C: -0.35%
CDMO M | $6.41 -1.69% -1.72% 790K
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: -3.04%
global report market
Cosmetic Surgery Market Report 2022-2032
Published: 2022-11-23 (Crawled : 14:20) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.29%
H: 0.72%
C: -2.46%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.1%
H: 0.62%
C: -0.35%
SIEN | $0.174 0.69% 3.4M
|
Health Technology
|
| O: 0.0%
H: 6.67%
C: -1.93%
report market
AbbVie to Present at the Evercore ISI HealthCONx Conference
Published: 2022-11-23 (Crawled : 13:20) - prnewswire.com
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.1%
H: 0.62%
C: -0.35%
conference
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Moderate to Severe Active Crohn's Disease
Published: 2022-11-23 (Crawled : 08:00) - prnewswire.com
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.1%
H: 0.62%
C: -0.35%
skyrizi treatment disease active approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.